• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

VVUS:US

4.8500 USD 0.0300 0.62%

As of 20:10:00 ET on 07/29/2014.

Snapshot for VIVUS Inc (VVUS)

Open: 4.8100 Day's Range: 4.7200 - 4.8700 Volume: 1,308,319
Previous Close: 4.8200 52wk Range: 4.5330 - 15.1500 1-Yr Rtn: -67.21%

Stock Chart for VVUS

No chart data available.
  • VVUS:US 4.8500
  • 1D
  • 1M
  • 1Y
4.8200
Interactive VVUS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VVUS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.2325
Est. EPS (USD) (12/2014) -1.1580
Est. PEG Ratio -
Market Cap (M USD) 501.08
Shares Outstanding (M) 103.31
30 Day Average Volume 1,556,829
Price/Book (mrq) 3.5420
Price/Sale (ttm) 4.3622
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VVUS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VVUS

VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. The company markets a treatment for erectile dysfunction, and has drugs for obesity and erectile dysfunction in late-stage clinical trials.

Seth H Z FischerCEO/Chief Commercial OfficerSvai SanfordInterim CFO
Lee B PerryVP/Chief Acctg Ofcr/Assistant SecyJohn L SlebirSenior VP:Bus Dev/Secy
More Company Profile & Key Executives for VVUS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil